Video
Emerging therapies for patients with penile cancer
Author(s):
“We still debate and there’s some good data that [supports that] chemotherapy is not that effective for patients with penile cancer,” says Philippe E. Spiess, MD, MS, FACS.
Video Player is loading.
In this video, Philippe E. Spiess, MD, MS, FACS, discusses the challenges of treating penile cancer and new treatment options for these patients, which were topics focused on at the 2021 Society of Urologic Oncology Annual Meeting. Spiess is a genitourinary oncologist and assistant chief of surgical services at the Moffitt Cancer Center in Tampa, Florida.
Related Videos
Gopa Iyer, MD, highlights findings from FORAGER-1 in metastatic urothelial carcinoma
Michael Schweizer, MD, shares data on mevrometostat plus enzalutamide in mCRPC
Laura Bukavina, MD, highlights study of urinary microbiome profiling
Kate Gessner, MD, on the mechanisms of immunotherapy failure in RCC
Darren Feldman, MD, on clinical outcomes in R/R testicular germ cell tumors
ASCO GU recap: Insights on 5 key trials
Laurence Albiges, MD, on COSMIC-313 trial of triplet vs doublet combination in aRCC
Francesca Jackson-Spence, MRCP, on efficacy of savolitinib/durvalumab in papillary renal cancer
Gopa Iyer, MD, on durable efficacy of EV/pembrolizumab in urothelial carcinoma
David Braun, MD, on phase 2 trial of an individualized neoantigen therapy for RCC
Related Content
